- Acute Myeloid Leukemia with 20-30% blasts in patients who are not eligible for Haemopoietic stem cell transplant
- High-risk Myelodysplastic syndrome (MDS)

AZASHINE 200MG TABLETS
| MRP | : |
|
| Price | : | ₹9,000.00 |
| You Save | : | ₹8,964.37 (49.9%) |
14 Tablet(s) In A Bottle
Azashine 200 mg tablet contains the active ingredient Azacitidine. It is prescribed for adults suffering from blood disorders, specifically Myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia, and Acute myeloid leukemia (AML), when they are deemed ineligible for a stem cell transplant.
In the case of Myelodysplastic Syndrome, the bone marrow fails to produce healthy blood cells due to its impaired function. Acute Myeloid Leukemia is a form of bone marrow cancer characterized by the release of improperly formed blood cells into the bloodstream. Chronic myelomonocytic leukemia is a rare type of blood cancer that results from an elevated count of monocytes among the white blood cells.